- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04344002
LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) (GRAVID)
Observational Retrospective Register of Spanish Lung and Melanoma Cancer Patients With COVID19 Disease
This is a multi-centre study on lung cancer patients which experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers and COVID-19 infection. Firstly, investigators will be registered in an online secure registry. After that, a protocol will be developed in order to collect clinical data for the research. It will also include I on the care organization or the perception of the patient and their family members.
The final stage will consist on retrospective data collection from patients. So, it is a retrospective study data collection, preceded by prospective data registry.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Alicante, Spain
- H. Gen. Universitario Alicante
-
Barcelona, Spain, 08036
- Hospital Clínic de Barcelona
-
Barcelona, Spain
- Hospital del Mar
-
Barcelona, Spain
- Hospital de la Santa Creu i Sant Pau
-
Barcelona, Spain, 08036
- H. Universitario Quirón Dexeus
-
Barcelona, Spain, 08907
- H. Duran i Reynals-ICO
-
Ciudad Real, Spain
- Hospital La Mancha Centro
-
Cuenca, Spain, 16002
- Hospital Virgen de La Luz
-
Cádiz, Spain
- Hospital Universitario de Puerto Real
-
Girona, Spain, 17007
- Hospital Dr. Josep Trueta
-
Granada, Spain
- Hospital Universitario Virgen de Las Nieves
-
Guadalajara, Spain, 19002
- Hospital de Guadalajara
-
León, Spain, 24071
- Complejo Asistencial Universitario de Leon
-
Logroño, Spain
- Hospital San Millan Y San Pedro
-
Lugo, Spain, 27003
- Hospital Universitario Lucus Augusti
-
Madrid, Spain
- Hospital General Universitario Gregorio Marañon
-
Madrid, Spain, 28040
- Fundación Jiménez Díaz
-
Madrid, Spain
- Hospital 12 de Octubre
-
Madrid, Spain, 28035
- H.U. Puerta de Hierro
-
Madrid, Spain
- Hospital Clinico San Carlos
-
Madrid, Spain, 28033
- MD Anderson
-
Madrid, Spain
- Hospital Universitario Infanta Leonor
-
Madrid, Spain
- Hospital Universitario de Fuenlabrada
-
Madrid, Spain, 28703
- Hospital Universitario Infanta Sofia
-
Madrid, Spain
- Hospital de Sanchinarro
-
Madrid, Spain
- Hospital Universitario del Henares
-
Murcia, Spain
- Hospital General Universitario Morales Meseguer
-
Málaga, Spain
- Hospital Carlos Haya
-
Ourense, Spain
- Hospital Santa Maria Nai
-
Palma de Mallorca, Spain, 07010
- Hospital Son Espases
-
Palma de Mallorca, Spain, 07198
- H. Son Llátzer
-
Salamanca, Spain, 37007
- Hospital Clínico de Salamanca
-
Segovia, Spain
- Hospital General de Segovia
-
Sevilla, Spain, 41013
- Hospital Virgen del Rocío
-
Tarragona, Spain, 43003
- Hospital Sant Pau i Santa Tecla
-
Tenerife, Spain
- Hospital Universitario Nuestra Señora Candelaria
-
Valencia, Spain
- Hospital Arnau de Vilanova
-
Valencia, Spain
- Instituto Valenciano de Oncología
-
Valencia, Spain
- Hospital Clínico Universitario de Valencia
-
Valencia, Spain
- Hospital Universitario Dr. Peset
-
Valencia, Spain
- Hospital Dr. Peset
-
Valencia, Spain, 46014
- H. General U. de Valencia
-
Valencia, Spain
- Hospital Politècnic i Universitari La Fe
-
Valladolid, Spain, 47003
- Hospital Clinico Universitario de Valladolid
-
Zaragoza, Spain, 50009
- H. Miguel Servet
-
Ávila, Spain
- Hospital Ntra. Sra. Sonsoles
-
-
A Coruña
-
Ferrol, A Coruña, Spain
- Complejo Hospitalario Universitario de Ferrol
-
-
Alicante
-
Benidorm, Alicante, Spain, 03501
- H. Clínica Benidorm
-
Elche, Alicante, Spain, 03202
- Hospital de Elche
-
Elda, Alicante, Spain, 03600
- Hospital General Universitario de Elda
-
Torrevieja, Alicante, Spain, 03186
- Hospital de Torrevieja
-
-
Barcelona
-
Badalona, Barcelona, Spain, 08916
- Hospital Universitari Germans Trias i Pujol
-
Esplugues De Llobregat, Barcelona, Spain
- Cetir Centre Mèdic
-
Granollers, Barcelona, Spain
- Hospital General de Granollers
-
-
Bizkaia
-
Galdakao, Bizkaia, Spain
- Hospital Universitario de Galdakao
-
-
Coruña
-
La Coruña, Coruña, Spain, 15006
- Complejo hospitalario de la coruña
-
-
Gran Canarias
-
Las Palmas De Gran Canaria, Gran Canarias, Spain, 35016
- H. Insular de Gran Canarias
-
-
La Rioja
-
Logroño, La Rioja, Spain
- Hospital San Pedro
-
-
Madrid
-
Alcorcón, Madrid, Spain, 28922
- Hospital Universitario Fundacion Alcorcon
-
Leganés, Madrid, Spain, 28911
- Hospital Severo Ochoa
-
Móstoles, Madrid, Spain
- Hospital Universitario de Móstoles
-
-
Mallorca
-
Manacor, Mallorca, Spain
- Hospital de Manacor
-
-
Málaga
-
Marbella, Málaga, Spain, 29603
- Hospital Costa del Sol
-
-
Navarra
-
Pamplona, Navarra, Spain, 31008
- Clinica Universitaria de Navarra
-
Pamplona, Navarra, Spain, 31008
- Clinica Universidad de Navarra
-
Pamplona, Navarra, Spain
- Complejo Hospitalario de Navarra
-
-
País Vasco
-
San Sebastián, País Vasco, Spain
- Hospital Instituto Onkologikoa
-
-
Tarragona
-
Reus, Tarragona, Spain, 43204
- Hospital Sant Joan de Reus
-
Tortosa, Tarragona, Spain
- Hospital Verge de la Cinta
-
-
Tenerife
-
La Laguna, Tenerife, Spain, 38320
- H. Universitario de Canarias
-
-
Valencia
-
Alzira, Valencia, Spain
- Hospital Universitario de La Ribera
-
Manises, Valencia, Spain
- Hospital de Manises
-
-
Vizcaya
-
Baracaldo, Vizcaya, Spain, 48903
- Hospital De Cruces
-
Bilbao, Vizcaya, Spain, 48013
- Hospital de Basurto
-
-
Áraba
-
Vitoria, Áraba, Spain, 01009
- Hospital Universitario de Araba
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients diagnosed with lung cancer
- Patients who have contracted COVID-19 infection
Exclusion Criteria:
- Patients diagnosed with lung cancer but no confirmation of COVID-19 infection.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
---|
lung cancer+COVID-19
lung cancer patients diagnosed with COVID-19
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical data of lung cancer patients with COVID-19 diagnoses
Time Frame: From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
|
Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as clinical data.
|
From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
|
Diagnosis data
Time Frame: From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
|
Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as data about diagnosis
|
From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
|
Treatments received
Time Frame: From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
|
Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as treatments received
|
From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
|
Prognostic factors
Time Frame: From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
|
Describe characteristics and evolution of Spanish patients preferably with lung cancer who contract COVID 19 infection with identification and study of factors of interest, as well as prognostic factors.
|
From the diagnosis of the COVID until the patient is cured or dies, whichever comes first, assessed up to 5 years
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Mariano MD Provencio, MD, Hospital Puerta de Hierro de Majadahonda de Madrid
- Study Chair: Cristina MD Avendaño Solá, MD, Hospital Puerta de Hierro de Majadahonda de Madrid
- Study Chair: María MD González-Cao, MD, Hospital Universitario Dexeus de Barcelona.
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GECP 20/02_GRAVID
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid-19
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
Massachusetts General HospitalRecruitingPost Acute COVID-19 Syndrome | Long COVID | Post Acute Sequelae of COVID-19 | Long COVID-19United States
-
Indonesia UniversityRecruitingPost-COVID-19 Syndrome | Long COVID | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19Indonesia
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNot yet recruitingPost-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post-COVID ConditionNetherlands
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecruitingCOVID-19 Pandemic | COVID-19 Vaccines | COVID-19 Virus DiseaseIndonesia
-
University of Witten/HerdeckeInstitut für Rehabilitationsforschung NorderneyCompletedPost-COVID-19 Syndrome | Long-COVID-19 SyndromeGermany
-
Jonathann Kuo, MDActive, not recruitingSARS-CoV2 Infection | Post-COVID-19 Syndrome | Dysautonomia | Post Acute COVID-19 Syndrome | Long COVID | Long Covid19 | COVID-19 Recurrent | Post-Acute COVID-19 | Post-Acute COVID-19 Infection | Post Acute Sequelae of COVID-19 | Dysautonomia Like Disorder | Dysautonomia Orthostatic Hypotension Syndrome | Post... and other conditionsUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityShangluo Central Hospital; Ankang Central Hospital; Hanzhong Central Hospital; Yulin... and other collaboratorsRecruitingCOVID-19 | Post-COVID-19 Syndrome | Post-Acute COVID-19 | Acute COVID-19China